tripathy
●    

2006-07-21 08:06
(6717 d 14:24 ago)

Posting: # 180
Views: 7,775
 

 Outlier consideration and re-dosing of Subjects [Regulatives / Guidelines]

Dear Forum member,

I am a Pharmacokinetist. I am new to this forum.
I went through some of the discussion topics, I found them really useful and decided to become a member of this forum.

I would like to ask forum members regarding the Statistical outlier consideration and re-dosing of subjects in a BE study. Whether outliers and re-dosing of subjects are acceptable by US-FDA regulatory, if yes then I would be very greatful to you if you provide me the link to any such guidance or correspondance from US-FDA.

Thanks and Regards,
Tripathy
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2006-07-21 15:33
(6717 d 06:57 ago)

@ tripathy
Posting: # 183
Views: 6,089
 

 Outlier consideration and re-dosing of Subjects

Hello Tripathy,

and welcome to the forum!

First have a look at this thread.
Personally I don't know any US-FDA's document regarding outliers.
You may find David Dubin's post (the last one on the page) at David Bourne's list interesting.

Generally speaking the more 'outlier conditions' you can justify in the protocol, the less trouble you will experience afterwards...
Post hoc exclusion is not a good idea!

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
tripathy
●    

2006-07-24 07:52
(6714 d 14:38 ago)

@ Helmut
Posting: # 187
Views: 5,892
 

 Outlier consideration and re-dosing of Subjects

Dear HS,

Thanks for the prompt reply. I will come back to you if I have any other doubts.

Regards,
Tripathy
UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,669 registered users;
38 visitors (0 registered, 38 guests [including 9 identified bots]).
Forum time: 21:31 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5